Press release
PEG Hydrogel-based Medical Device Market Revenue Share, Insights & Future Outlook
Polyethylene glycol (PEG) materials offer solubility, good biocompatibility, non-toxicity, and low immunogenicity. They are widely used in medical treatments such as wound adhesion, hemostasis, leakage prevention, and adhesion prevention during surgical operations. PEG-based hydrogels can also serve as raw materials for medical devices implanted in the human body, replacing traditional plant-, animal-, or human-source materials.When sprayed onto a wound, PEG-based hydrogel rapidly solidifies to prevent bleeding and infection, then degrades naturally after healing. Applied on organ surfaces during surgery, it prevents internal adhesions without causing abnormal reactions. PEG derivatives are fully metabolized and excreted, ensuring safety and biocompatibility.
What is Driving Growth in the PEG Hydrogel-based Medical Device Market?
The global PEG Hydrogel-based Medical Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Download Free Data: https://reports.valuates.com/request/sample/QYRE-Auto-16V17279/Global_PEG_Hydrogel_based_Medical_Device_Market_Research_Report_2024?utm_source=Openpr&utm_medium=Referral
How Will Regional Markets Like North America and Asia-Pacific Perform?
North American market for PEG Hydrogel-based Medical Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for PEG Hydrogel-based Medical Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Which Companies Are Leading the PEG Hydrogel-based Medical Device Market?
The major global manufacturers of PEG Hydrogel-based Medical Device include Baxter, Becton Dickinson, Boston Scientific, Cardinal Health, Medtronic, Stryker, Integra LifeSciences, Pramand, Success Bio-Tech, Medprin Biotech, etc. In 2023, the top three vendors accounted for approximately % of global revenue.
Market Segmentation
By Type
• 4-Arm PEGs
• 8-Arm PEGs
• Multi-Arm PEGs
By Application
• Surgical Closure and Hemostasis
• Radiation Therapy Tissue Barrier
Key Companies in the Market
• Baxter - Specializes in medical devices and biopharmaceuticals, including PEG-based hydrogel solutions.
• Becton Dickinson - Offers innovative healthcare solutions including surgical and wound care devices.
• Boston Scientific - Develops advanced medical devices for minimally invasive procedures.
• Cardinal Health - Provides a wide range of surgical and healthcare products including PEG hydrogels.
• Medtronic - Global leader in medical technology with expertise in surgical and therapeutic devices.
• Stryker - Known for advanced surgical equipment and innovative wound care solutions.
• Integra LifeSciences - Specializes in medical devices for surgery, neurology, and tissue regeneration.
• Pramand - Provides biomedical solutions including tissue barrier and hemostasis products.
• Success Bio-Tech - Focused on PEG-based hydrogels and bioactive medical materials.
• Medprin Biotech - Offers biomaterials and medical device solutions, including hydrogel products.
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-16V17279/global-peg-hydrogel-based-medical-device?utm_source=Openpr&utm_medium=Referral
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PEG Hydrogel-based Medical Device Market Revenue Share, Insights & Future Outlook here
News-ID: 4206327 • Views: …
More Releases from Valuates Reports
Data Backup and Recovery Software Market Size, Trends & Forecasts | Valuates Rep …
Data Backup and Recovery Software Market Size
The global market for Data Backup and Recovery Software was estimated to be worth US$ 5571.8 million in 2023 and is forecast to a readjusted size of US$ 10800 million by 2030 with a CAGR of 9.8% during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-17P7024/China_Data_Backup_and_Recovery_Software_Market_Report_Forecast_2021_2027?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral
Veeam, Veritas Technologies, Commvault, Acronis, Kaseya (Unitrends), Datto, Netapp, Code42 etc. are the key suppliers in the global Data Backup…
Data Center Cable Management Market Research Report (2024-2030) | Valuates Repor …
Data Center Cable Management Market:
The global Data Center Cable Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Key growth drivers include:
• Demand for higher-density and scalable cabling systems
• AI-driven increases in compute capacity
• Rapid cloud adoption and edge deployments
• Need for efficient airflow and cooling
• Growth of modular, prefabricated data center designs
• Regulatory compliance, uptime demands, and operational…
Cloud Computing Data Center IT Asset Disposition (ITAD) Market Set to Surge - Ke …
Cloud Computing Data Center IT Asset Disposition (ITAD) Market Size
The global Cloud Computing Data Center IT Asset Disposition (ITAD) revenue was US$ 6050.4 million in 2022 and is forecast to a readjusted size of US$ 12270 million by 2029 with a CAGR of 10.5% during the review period (2023-2029).
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10H16125/Global_and_India_Cloud_Computing_Data_Center_IT_Asset_Disposition_ITAD_Market_Report_Forecast_2023_2029?utm_source=openpr&utm_medium=referral
Companies that provide Cloud Computing Data Center IT Asset Disposition (ITAD) mainly include Sims Recycling, IBM, HPE, etc. These…
Edge Data Center Market Set to Surge - Key Insights You Must Know
Edge Data Center Market
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Edge Data Centers estimated at USD 1275 million in the year 2022, is projected to reach a revised size of USD 2354.1 million by 2028, growing at a CAGR of 10.8% during the forecast period 2022-2028. The Edge Data Center Market is expanding as a result of the adoption of SDN and NFV…
More Releases for PEG
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.
PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By…
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications.
"Biopharma PEG is committed to delivering high-purity multi-arm…
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development.
Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due…
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition…
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in…
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,…
